Sfoglia per AUTORE
BERARDI R
Collezione ASL Cuneo 2
Items : 2
Global real-world experiences with pembrolizumab in advanced urothelial carcinoma after platinum-based chemotherapy: the ARON-2 study. in Cancer immunology, immunotherapy : CII / Cancer Immunol Immunother. 2024 Apr 18;73(6):106. doi: 10.1007/s00262-024-03682-w.
2024
ASL Cuneo 2
ASL Cuneo 2
Massari F; Santoni M; Takeshita H; Okada Y; Tapia JC; Basso U; Maruzzo M; Scagliarini S; Büttner T; Fornarini G; Myint ZW; Galli L; Souza VC; Pichler R; De Giorgi U; Gandur N; Lam ET; Gilbert D; Popovic L; Grande E; Mammone G; Berardi R; Crabb SJ; Kemp R; Molina-Cerrillo J; Freitas M; Luz M; Iacovelli R; Calabrò F; et alii...
Safety of extended interval dosing immune checkpoint inhibitors: a multicenter cohort study. in Journal of the National Cancer Institute / J Natl Cancer Inst. 2023 Jul 6;115(7):796-804. doi: 10.1093/jnci/djad061.
2023
ASL Cuneo 2
ASL Cuneo 2
Cantini L; Paoloni F; Pecci F; Spagnolo F; Genova C; Tanda ET; Aerts S; Rebuzzi SE; Fornarini G; Zoratto F; Fancelli S; Lupi A; Della Corte CM; Parisi A; Bennati C; Ortega C; Atzori F; Piovano PL; Orciuolo C; De Tursi M; Ghidini M; Botticelli A; Scagnoli S; Belluomini L; Leporati R; Veccia A; Di Giacomo AM; Festino L; Cortinovis D; et alii...